Drug Profile
Midazolam injection - Alfresa Pharma
Alternative Names: AF 0901; MidafresaLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator Alfresa Pharma Corporation
- Class Antiepileptic drugs; Benzodiazepines; Chlorinated hydrocarbons; Fluorobenzenes; Hypnosedatives; Imidazoles; Sleep disorder therapies; Small molecules
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Epilepsy
Most Recent Events
- 07 Feb 2019 Chemical structure information added
- 26 May 2017 Alfresa Pharma completes a phase III trial for Epilepsy (In neonates, In infant, In children, In adolescents) in Japan before May 2017 (JapicCTI-173586)
- 01 May 2017 Alfresa Pharma initiates enrolment in a phase III trial for Epilepsy (In neonates, In infant, In children, In adolescents) in Japan before May 2017 (JapicCTI-173586)